Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Rhea-AI Summary

Novavax (Nasdaq: NVAX) has scheduled its second quarter 2025 financial results and operational highlights conference call for August 6, 2025, at 8:30 a.m. ET. The company will host a conference call with both domestic and international dial-in options, and participants can register online for automated callback access.

A replay of the conference call will be available from 11:30 a.m. ET on August 6 until August 13, 2025. The webcast replay will remain accessible on the company's investor relations website until September 5, 2025.

News Market Reaction

-2.28%

1 alert

-2.28% News Effect

On the day this news was published, NVAX declined 2.28%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

GAITHERSBURG, Md., July 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its second quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Wednesday, August 6, 2025. Details of the event and replay are as follows:

Conference call details:
Date:	August 6, 2025
Time:	8:30 a.m. U.S. ET
URL to register phone:	Register Here
Dial-in number:	(888) 880-3330 (Domestic) or
	(+1) (646) 357-8766 (International)
Webcast:	ir.novavax.com/events

• Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
• Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
• To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled start time.

Replay details:
Date:	Available starting at 11:30 a.m. U.S. ET, August 6, 2025, until 11:59 p.m. U.S. ET, August 13, 2025
Dial-in number:	(800) 770-2030 (Domestic) or
	(+1) (609) 800-9909 (International)
Passcode:	3041984#
Webcast:	ir.novavax.com/events, until September 5, 2025

About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M^® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information.

Contacts: 

Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com

Media
Giovanna Chandler
844-264-8571
media@novavax.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-report-second-quarter-2025-financial-results-on-august-6-2025-302516855.html

SOURCE Novavax, Inc.

FAQ

When will Novavax (NVAX) report Q2 2025 earnings?

Novavax will report its Q2 2025 financial results on Wednesday, August 6, 2025, at 8:30 a.m. Eastern Time.

How can investors access Novavax's Q2 2025 earnings call?

Investors can access the call through the webcast at ir.novavax.com/events or by phone using domestic (888) 880-3330 or international (+1) 646-357-8766 numbers after registering online.

How long will Novavax's Q2 2025 earnings call replay be available?

The call replay will be available from 11:30 a.m. ET on August 6 until August 13, 2025, while the webcast replay will be accessible until September 5, 2025.

What is the passcode for Novavax's Q2 2025 earnings call replay?

The replay passcode is 3041984#. Investors can access it via domestic (800) 770-2030 or international (+1) 609-800-9909 numbers.